Αρχική World News Partnership in a pandemic: how Credit Suisse delivered an incredible Charity of...

Partnership in a pandemic: how Credit Suisse delivered an incredible Charity of the Year partnership despite lockdown

Collage of Credit Suisse's fundraising endeavours

In January 2020, we were thrilled to launch our partnership with Credit Suisse, the global investment bank, as their UK Charity of the Year. We couldn’t have imagined that a few months into the initiative, COVID-19 would result in a national lockdown that would drastically change the fundraising landscape. However, despite the constraints the pandemic placed on them, employees at Credit Suisse have raised nearly £2m through an innovative series of staff fundraising events and generous corporate donations. As a celebration of their amazing fundraising, and as a thank you for extending the partnership to December 2021, we explore how Credit Suisse adapted its plans to run an extraordinary Charity of the Year partnership during a pandemic.

The Credit Suisse UK Charity of the Year programme began in 2008 and has raised over £14m for good causes. Staff can nominate charities close to their hearts and then vote on a shortlist of charities they would like to support that year. Whilst the bank supports several charities through grants and skills-based volunteering, their Charity of the Year stands to benefit from Credit Suisse’s fundraising activities.

Their sustained commitment to fundraising has seen Credit Suisse build a stellar calendar of tried and tested fundraising activities. Sadly, this all had to be put hold in 2020, but Credit Suisse employees didn’t let that stop them. Jog LEJOG – a running challenge from Land’s End to John O’Groats – became a successful virtual event which, without the need for travel, was a more inclusive opportunity for colleagues. They were even able to include colleagues from across Europe, showing that no matter where you’re based, you can come together to fundraise and stay active. Similarly, the All Staff Quiz became a virtual comedy evening with a twist – with staff donating to vote for which senior member of staff would be put in the spotlight for a ribbing from well-known comedians.

Going above and beyond

At the outset of the partnership, before COVID-19 hit, Credit Suisse’s aim was to raise £800k to fully fund a research project into how immunotherapy could become a viable treatment option for more people with cancer. Thanks to their innovation and perseverance, Credit Suisse employees smashed their target – raising a staggering £1.85m in hugely challenging circumstances. This means that they not only fully funded the original research project but donated to CRUK’s Nurse Helpline too, which saw an increase in calls from people worried about cancer diagnosis and treatment at the start of the pandemic. They have also agreed to extend the partnership to December 2021 and fund our Health Facilitator Programme, in which teams of experts work with health professionals in deprived areas of the UK to prevent and diagnose cancers sooner.

“Credit Suisse has truly demonstrated incredible support for our partnership when we needed them the most.”

And Credit Suisse did more than just fundraising. Together we set ourselves some strategic objectives for the partnership, including promoting a healthy lifestyle to staff. Over the past year, we’ve worked closely with them to raise awareness among staff of the small lifestyle changes that can help reduce their cancer risk.

“Credit Suisse has truly demonstrated incredible support for our partnership when we needed them most. It was a difficult year for us, but Credit Suisse employees stepped up to support us with this challenge and we have been absolutely blown away by their efforts” says Caro Evans, Director of Partnerships at Cancer Research UK. “We are thrilled to continue our partnership in 2021. This is such an exciting opportunity to fund more of our vital work. We could not be more thankful and we look forward to seeing what the partnership has in store for the future.”

Rising to the challenge

Like many businesses, Credit Suisse has had to overcome challenges as a result of the pandemic – not least remote working. Remote working became the norm across the country but as a new of working for staff at the bank, was quite an adjustment. Utilising tech innovations and an agile approach to working, their employees have risen to the challenge with enthusiasm and dedication, just as they did with their fundraising. Their Charity of the Year committee and various staff across the organisation suggested innovative ways to engage with our work, and we’re thrilled to see their passion and commitment being recognised by being shortlisted for Best Corporate Partnership in the Banks and Financial Services Category at the Business Charity Awards.

Edward Bowers is senior partnership relations executive at Cancer Research UK

Find out more about partnerships at Cancer Research UK

More on this topic

Source

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...

ΠΑΓΚΟΣΜΙΑ ΗΜΕΡΑ ΚΑΡΚΙΝΟΥ

Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

10 Ways You Can Nurture A More Sustainable Garden

Sustainable gardening doesn’t have a firm, technical definition. It’s the concept of using sustainable gardening techniques that not only cause no harm to the...

Cancer Research UK spin-out gets US approval to trial unique T cell therapy

Cancer Research UK’s spin-out, GammaDelta Therapeutics (‘GammaDelta’), has been given approval from the US Food and Drug Administration (FDA) to trial its unique T-cell...

Platinum-Based Chemotherapy Versus Capecitabine in Patients With Residual TNBC Following Neoadjuvant Chemotherapy

The ECOG-ACRIN EA1131 study hypothesised that invasive disease-free survival (iDFS) would not be inferior but improved in patients with basal subtype triple-negative breast cancer...

Adding Checkpoint Inhibition to Anti-HER2 Breast Cancer Therapy Brings no Benefit [ESMO Virtual Plenary Press Release]

VP6-2021 - IMpassion050: A phase III study of neoadjuvant atezolizumab + pertuzumab + trastuzumab + chemotherapy (neoadj A + PH + CT) in high-risk,...

Breaking News: Supreme Court Upholds the Affordable Care Act

It’s a great day for cancer survivors. The Supreme Court of the United States (SCOTUS) upheld the Affordable Care Act (ACA), commonly known as...

How Does CAR T-Cell Therapy Work in Treating Cancer?

Craig A. Portell, MD, is an Associate Professor of Medicine at the University of Virginia and a member of the UVA Cancer Center in...